摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(4-chlorophenyl)methyl]-1-(1-naphthalen-1-ylsulfonylpyrrolidin-3-yl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine | 1384516-41-9

中文名称
——
中文别名
——
英文名称
N-[(4-chlorophenyl)methyl]-1-(1-naphthalen-1-ylsulfonylpyrrolidin-3-yl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine
英文别名
——
N-[(4-chlorophenyl)methyl]-1-(1-naphthalen-1-ylsulfonylpyrrolidin-3-yl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine化学式
CAS
1384516-41-9
化学式
C27H26ClN3O4S2
mdl
——
分子量
556.106
InChiKey
POWWGDXZERDDKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    123
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] MODULATORS OF REV-ERB<br/>[FR] MODULATEURS DE REV-ERB
    申请人:KAMENECKA THEODORE MARK
    公开号:WO2013033310A1
    公开(公告)日:2013-03-07
    The subject matter herein concerns the identification and development of potent synthetic REV-ERB ligands, such as in vivo agonists and antagonists. These compounds allow for characterization of the effects of modulation of this receptor in vivo specifically on circadian behavior and metabolism, and have suitable characteristics for development of medicinal compounds useful for treatment of malconditions such as diabetes, obesity, atherosclerosis, dyslipidemia, a circadian rhythm disorder, coronary artery disease, bipolar disorder, depression, cancer, a sleep disorder, an anxiety disorder, an addiction disorder, or an autoimmune disorder.
  • Small molecule tertiary amines as agonists of the nuclear hormone receptor Rev-erbα
    作者:Youseung Shin、Romain Noel、Subhashis Banerjee、Douglas Kojetin、Xinyi Song、Yuanjun He、Li Lin、Michael D. Cameron、Thomas P. Burris、Theodore M. Kamenecka
    DOI:10.1016/j.bmcl.2012.04.126
    日期:2012.7
    The structure-activity relationship study of a small molecule Rev-erb alpha agonist is reported. The potency and efficacy of the agonists in a cell-based assay were optimized as compared to the initial lead. Modest mouse pharmacokinetics coupled with an improved in vitro profile make 12e a suitable in vivo probe to interrogate the functions of Rev-erba in animal models of disease (C) 2012 Elsevier Ltd. All rights reserved.
查看更多